Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prohovnik, I.
Right arrow Articles by Haroutunian, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prohovnik, I.
Right arrow Articles by Haroutunian, V.
Related Collections
Right arrow All Cognitive Disorders/Dementia
Right arrow Alzheimer's disease
NEUROLOGY 2006;66:49-55
© 2006 American Academy of Neurology

Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease

I. Prohovnik, PhD, D. P. Perl, MD, K. L. Davis, MD, L. Libow, MD, G. Lesser, MD and V. Haroutunian, Ph

From the Department of Psychiatry, Mount Sinai School of Medicine, New York, NY (I.P., D.P.P., K.L.D., V.H.); Bronx VA Medical Center, Bronx, NY (I.P., V.H.); and the Jewish Home and Hospital, New York, NY (L.L., G.L.).

Address correspondence and reprint requests to Dr. Isak Prohovnik, MIRECC (00MH), Bronx VAMC, 130 West Kingsbridge Road, Bronx, NY 10468; e-mail: isak.prohovnik{at}mssm.edu

Background: Little is known about Alzheimer disease at advanced ages, although its incidence continues to increase at least through the ninth decade of life.

Objective: To examine the effects of age on the relationship between clinical dementia severity and neuropathologic hallmarks in a large sample spanning the full age range.

Methods: The authors assessed 81 subjects during life for dementia severity, and examined their brains. They analyzed plaque and tangle burden, as well as the activities of the cholinergic marker enzymes acetylcholinesterase (AChE) and choline acetyltransferase (ChAT), in relation to age at death and the clinical severity of dementia.

Results: Dementia severity was strongly related to plaque and tangle burden in relatively young patients (aged <75 years), but this correlation diminished with age and disappeared in the ninth decade of life. Among the oldest patients studied, there was no difference in plaque and tangle load between the mild and severe dementia cases. This interaction (p < 0.0001 for plaque density) was not observed for the cholinergic markers ChAT and AChE.

Conclusion: The nature or expression of Alzheimer disease may be different in severely demented older patients, who have equal cholinergic deficits but significantly lower plaque and tangle burden. If confirmed in a prospective study, these findings have diagnostic and therapeutic implications.

Supported in part by NIH grants P01-AG02219 and P50-AG05138.

Disclosure: The authors report no conflicts of interest.

These data were partially presented at the First Congress of the International Society for Vascular Behavioral and Cognitive Disorders, Goteborg, Sweden, August 28 through 31, 2003.

Received February 17, 2005. Accepted in final form September 29, 2005.




This article has been cited by other articles:


Home page
 Arch NeurolHome page
V. Haroutunian, M. Schnaider-Beeri, J. Schmeidler, M. Wysocki, D. P. Purohit, D. P. Perl, L. S. Libow, G. T. Lesser, M. Maroukian, and H. T. Grossman
Role of the Neuropathology of Alzheimer Disease in Dementia in the Oldest-Old
Arch Neurol, September 1, 2008; 65(9): 1211 - 1217.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
T. D. Koepsell, B. F. Kurland, O. Harel, E. A. Johnson, X. -H. Zhou, and W. A. Kukull
Education, cognitive function, and severity of neuropathology in Alzheimer disease
Neurology, May 6, 2008; 70(19_Part_2): 1732 - 1739.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. P. Meyer, A. Ulmann-Schuler, M. Staufenbiel, and T. Krucker
Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease
PNAS, March 4, 2008; 105(9): 3587 - 3592.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
K. E. Pike, G. Savage, V. L. Villemagne, S. Ng, S. A. Moss, P. Maruff, C. A. Mathis, W. E. Klunk, C. L. Masters, and C. C. Rowe
{beta}-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease
Brain, November 1, 2007; 130(11): 2837 - 2844.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
D. J. Berlau, K. Kahle-Wrobleski, E. Head, M. Goodus, R. Kim, and C. Kawas
Dissociation of Neuropathologic Findings and Cognition: Case Report of an Apolipoprotein E {varepsilon}2/{varepsilon}2 Genotype
Arch Neurol, August 1, 2007; 64(8): 1193 - 1196.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. C. Rowe, S. Ng, U. Ackermann, S. J. Gong, K. Pike, G. Savage, T. F. Cowie, K. L. Dickinson, P. Maruff, D. Darby, et al.
Imaging {beta}-amyloid burden in aging and dementia
Neurology, May 15, 2007; 68(20): 1718 - 1725.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Edison, H. A. Archer, R. Hinz, A. Hammers, N. Pavese, Y. F. Tai, G. Hotton, D. Cutler, N. Fox, A. Kennedy, et al.
Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study
Neurology, February 13, 2007; 68(7): 501 - 508.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by AAN Enterprises, Inc.